Several other research firms have also recently commented on MON. S&P Equity Research restated a positive rating on shares of Monsanto in a research report on Thursday, September 15th. Vetr upgraded Monsanto from a buy rating to a strong-buy rating and set a $116.55 price target on the stock in a research report on Monday, June 27th. Piper Jaffray Cos. reiterated an overweight rating and set a $118.00 price target on shares of Monsanto in a research report on Sunday, August 21st. Citigroup Inc. reiterated a neutral rating and set a $112.00 price target on shares of Monsanto in a research report on Monday, July 18th. Finally, Goldman Sachs Group Inc. set a $92.00 price target on Monsanto and gave the company a sell rating in a research report on Monday, June 27th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of $114.67.
Shares of Monsanto (NYSE:MON) traded up 0.07% during mid-day trading on Thursday, hitting $103.57. The stock had a trading volume of 974,005 shares. Monsanto has a 12-month low of $83.73 and a 12-month high of $114.26. The company has a 50 day moving average price of $104.88 and a 200 day moving average price of $101.34. The firm has a market cap of $45.32 billion, a P/E ratio of 45.59 and a beta of 1.19.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm had revenue of $2.56 billion for the quarter, compared to analysts’ expectations of $2.38 billion. During the same period last year, the firm earned ($0.19) EPS. The firm’s revenue was up 8.8% compared to the same quarter last year. Equities analysts forecast that Monsanto will post $4.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.
In related news, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Corporate insiders own 0.88% of the company’s stock.
A number of hedge funds have recently bought and sold shares of MON. FMR LLC raised its stake in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the period. Third Point LLC bought a new position in Monsanto during the second quarter worth approximately $206,820,000. Carmignac Gestion bought a new position in Monsanto during the second quarter worth approximately $197,555,000. TIAA CREF Investment Management LLC boosted its position in Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock worth $481,732,000 after buying an additional 1,560,646 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. boosted its position in Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock worth $176,327,000 after buying an additional 1,147,200 shares in the last quarter. 79.02% of the stock is currently owned by institutional investors and hedge funds.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.